Articles by William Looney - Pharmaceutical Executive


Articles by William Looney

William Looney

How the "Millennials" Demographic is Shaping US Healthcare
October 6, 2014

The US is skewing young again, and the "millennials" have the clout to color everything from the nation's cultural landscape to the conduct of business practices like marketing and customer engagement, writes Bill Looney.

IDEAlogue for Innovation
October 1, 2014

Professor Fabio Pammolli, a leading European economist and policy advisor to the key EU institutions, outlines the current dilemma facing health and pharma regulators in Europe today.

October 1, 2014

You may not realize it, but the demographic "youth skew" in America is shaping healthcare—and that's a good thing.

Ireland's Celtic Tiger: Back on the Hunt
September 1, 2014

Leaders from industry, government, and the CRO community examine Ireland's future as a magnet for life science investments, and what the nation must do to remain the leading exporter of finished pharmaceutical products.

13 Years Right
September 1, 2014

Pharm Exec's latest Industry Audit sticks to the series' longtime standard of emphasizing transparent indicators of shareholder value.

Brown University's Masters in Healthcare Leadership: A Mission to Transform
August 1, 2014

Mid-career students on Brown University's new program are challenged to remove the organizational silos that slow innovations in the delivery and financing of healthcare.

A Window on the Industry: The Emerging Pharma Leaders 2014
August 1, 2014

Pharm Exec's 2014 roster of emerging pharma leaders serves as a window on work in an industry that relies on human capital as the coinage of success, writes William Looney.

Pharm Exec's 2014 Dealmakers Outlook
July 10, 2014

As the pacing picks up around dealmaking as the alternative to organic growth, Pharm Exec brings together experts from big Pharma and biotech to dissect the road ahead for M&A, licensing, and partnership activity.

The Peace Dividend
July 10, 2014

A surprising takeaway from the recent BIO Convention, writes William Looney, is the stark contrast between cooperative industry engagement and an unstable geopolitical order.


Click here